Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …

Gastroenteropancreatic neuroendocrine neoplasia (GEP-NEN) is a heterogeneous and
complex group of tumors that are often difficult to classify due to their heterogeneity and …

Rationale and Objectives Tumor grading of nonfunctional pancreatic neuroendocrine tumors
(NF-pNETs) determines the choice of clinical treatment and management. The pathological …

Introduction Pancreatic neuroendocrine tumors (PNETs) in hereditary syndromes pose a
significant challenge to clinicians. The rarity of these syndromes and PNETs itself make it …

Simple Summary Pancreatic neuroendocrine tumors (PanNETs) and lung NETs (LNETs)
have garnered increased attention in recent years due to their diverse clinical manifestations …

Purpose The decreased life expectancy of MEN-1 patients is mainly related to pancreatic
neuroendocrine tumors (pNETs). At best, limited data is available on the natural history of …

Multiple Endocrine Neoplasia type-1 (MEN1) is an autosomal dominant disorder with a
combined occurrence of tumours of parathyroid glands, pancreatic islets, and anterior …

Pancreatic neuroendocrine tumours (pNETs) are a major manifestation of multiple
endocrine neoplasia type 1 (MEN1), and the most significant cause of morbidity and …

Zusammenfassung Etwa 5–10% der duodenopankreatischen neuroendokrinen Neoplasien
(dpNEN) treten im Zusammenhang mit einem erblichen Tumorsyndrom auf. Die häufigste …

Gastroenteropancreatic neuroendocrine tumors (GEP NETs) comprise a heterogenous and
diverse group of neoplasms arising from a common neuroendocrine cell origin. The majority …